What is the state of science behind minor cannabinoids really like?

Minor cannabinoids are gaining increasing interest – pushed by both slowly growing consumer awareness and companies looking to develop further revenue streams from under-utilised products.

A number of claims have been made about the properties of various minor cannabinoids – some skirting dangerously close to the line of what is currently permitted and some going well over that health claims line.

In reality, the science behind the potential of minor cannabinoids is significantly behind where it should be – like much of the rest of the investigation into the benefits of cannabis – stymied by restrictions and stigma.

Subscribe to our Newsletter

Join in to hear about news, events, and podcasts in the sector

"*" indicates required fields

Corporate Email*

Name*

Comments

This field is for validation purposes and should be left unchanged.

Nonetheless, some advances have been made. CBD-Intel has recently published a guide to the most commercially important minor cannabinoids, outlining what their potential effects could be and where the state of the science behind those claims is currently.

Feel free to submit your questions for our next blog post*

*Under CBD-Intel’s editorial discretion

CannIntelligence

This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.